** Shares of Israel-based drug developer SciSparc SPRC.O rise 45% to $6.18 premarket
** SciSparc shareholders approved a merger with Israeli vehicle importer AutoMax
** SPRC shareholders will hold about 50.01% of the combined company post-merger
** The merger will make AutoMax a wholly-owned subsidiary of SciSparc
** The merger still requires Israeli court approval and AutoMax shareholder votes
** As of last close, stock down 43.7% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))